Global Single-Cell Omics Market Insights Forecasts to 2032
- The Global Single-Cell Omics Market Size was valued at USD 1.78 Billion in 2022.
- The Market Size is Growing at a CAGR of 15.50% from 2022 to 2032
- The Worldwide Single-Cell Omics Market Size is expected to reach USD 7.52 Billion by 2032
- Asia Pacific is expected to Grow the fastest during the forecast period
Get more details on this report -
The Global Single-Cell Omics Market Size is expected to reach USD 7.52 Billion by 2032, at a CAGR of 15.50% during the forecast period 2022 to 2032.
Single-cell omics is concerned with the profiling of single cells drawn from a heterogeneous population of cells in various cellular states. Single-cell omics has recently sparked a lot of interest due to its wide range of applications in drug discovery and research, particularly in oncology. The market is governed by a number of players, with their own competitive advantage that has allowed them to gain a foothold in this competitive market. Entry barriers are frequently extremely high in such a niche market as single-cell omics, which is dominated by established players. Despite this, due to recent advancements in research and the occurrence of pandemics, global interest has shifted towards this market, as evidenced by an increase in investments worldwide. Furthermore, single-cell omics are becoming more common as a result of continuous technological advancements, and they help to discover new and rare cell types as well as decipher disease pathogenesis and outcome. Single-cell omics has enormous potential for deciphering virus biology and virus-host cell interactions, and it is a powerful tool in virology that should be used more frequently in the future such factors are boost the market growth in forecast period.
Global Single-Cell Omics Market Report Coverage
|Market Size in 2022:
|USD 1.78 Billion
|Forecast Period 2022-2032 CAGR:
|2032 Value Projection:
|Historical Data for:
|No. of Pages:
|Tables, Charts & Figures:
|By Type, By Application, By End-User and By Region
|Bio-Rad Laboratories, Inc., Celsee, Inc., BGI Genomics Co. Ltd., GE LifeSciences, Illumina, Inc., 10x Genomics, Inc., Fluxion Biosciences, Takara Bio, QIAGEN N.V., 1CellBio, MissionBio, NanoString Technologies, Inc., Fluidigm Corporation, and Others.
|Pitfalls & Challenges:
|COVID-19 Empact, Challenges, Future, Growth, & Analysis
Get more details on this report -
Technological advancements in single-cell analysis and an increase in large-scale genomics studies leveraging single-cell RNA sequencing are driving the market. Other factors driving market growth include the rapidly expanding biotechnology and biopharmaceutical industries, as well as rising demand for biologics. New single-cell platforms make separation and analysis easier, and in some cases, both the potential development of these technologies and their limitations are rapidly being developed and proving to be of increasing interest to researchers, particularly in the field of single-cell genomics such factors are boost market growth in forecast period. Furthermore, the rise in the prevalence of life-threatening conditions has increased demand for personalised medicine. Single-cell technology advancements are making it possible to discern biological insights within individual cells. Single-cell technologies can be roughly divided into those that allow for single-cell separation and those that allow for single-cell analysis.
Single-cell omics technologies have the potential to provide significant insights and benefits, but the costs associated with implementing and conducting single-cell analyses can be significant barriers to widespread adoption such factors hamper the market growth in the forecast period.
By Type Insights
The single-cell genomics segment dominates the market with the largest revenue share over the forecast period.
On the basis of type, the global single-cell omics market is segmented into single-cell genomics, and single-cell transcriptomics. Among these, the single-cell genomics segment is dominating the market with the largest revenue share over the forecast period. Single-cell genomics can be used to diagnose clinical diseases, and huge advances in healthcare, particularly in liquid biopsies, have paved the way for this single-cell omics market to grow. Increasing demand from a diverse range of end users, potential clinical applications of single-cell genomics platforms, and technological advancements Microfluidics, high-throughput sequencing platforms, and droplet-based methods allowed researchers to study cellular heterogeneity at unprecedented resolution.
By Application Insights
The oncology segment is witnessing significant CAGR growth over the forecast period.
On the basis of application, the global single-cell omics market is segmented into oncology, neurology and others. Among these, the oncology segment is witnessing significant growth over the forecast period. The study of cancer is known as oncology. The increasing prevalence of cancer, continuous advancements in single-cell analysis methods, and the growing use of omics-based instruments for investigating cancer progression. The incorporation of single-cell metabolomics into cancer detection due to its enhanced ability to detect cancer cells with increased sensitivity is expected to accelerate market trends. Furthermore, scientists are investigating various applications of single-cell technologies in domains such as genomics, transcriptomics, proteomics, and metabolomics.
By End- User Insights
The academic and research organizations segment is expected to hold the largest share of the global single-cell omics market during the forecast period.
Based on the end user, the global single-cell omics market is classified into pharma & biotech companies, academic and research organizations, hospital laboratories and others. Among these, the academic and research organizations segment is expected to hold the largest share of the single-cell omics market during the forecast period. The increasing use of technology on college campuses, increased research efforts to develop novel modelling tools, and increased research studies by various research institutes to investigate diverse applications of cellular biology are expected to drive segment growth. Furthermore, researchers are investigating numerous applications of single-cell technologies in fields such as transcriptomics, genomics, proteomics, epigenomics, and metabolomics.
North America dominates the market with the largest market share over the forecast period.
Get more details on this report -
North America is dominating the market with the largest market share over the forecast period. Several market players' presence and various developments are some of the key factors driving regional growth. Furthermore, the presence of advanced healthcare and increasing R&D activities for the development of novel technologies are driving the regional market. Furthermore, favorable government legislation, the growing importance of cellular therapies, and the growing trend towards precision medicine are bolstering the regional market. For example, the United States has launched the Precision Medicine Initiative to improve health and treat diseases. The combination of single-cell omics with medical technologies allows for more precise disease analysis and patient stratification, driving demand for single-cell omics technologies in the region.
Asia-Pacific is expected to grow the fastest during the forecast period. The region's single-cell omics market is expected to be driven by factors such as the increasing burden of target diseases and rising demand for advanced therapeutics. The growing interest of market players in capturing untapped market potential, as well as their increasing investments in the region, is facilitating the region's market growth. Furthermore, expanding agreements among companies to strengthen their market avenues is another potential factor driving the regional market.
List of Key Market Players
- Bio-Rad Laboratories, Inc.
- Celsee, Inc.
- BGI Genomics Co. Ltd.
- GE LifeSciences
- Illumina, Inc.
- 10x Genomics, Inc.
- Fluxion Biosciences
- Takara Bio
- QIAGEN N.V.
- NanoString Technologies, Inc.
- Fluidigm Corporation
Key Market Developments
- On July 2023, BD presented a new single-cell multi-omics analysis tool. It enables researchers to conduct high-throughput studies without jeopardising sample integrity, potentially speeding up the pace of discovery in a wide range of fields.
- On April 2023, Fulgent Genetics launched the Mission Bio platform to make single-cell multi-omics more accessible for drug development and clinical research. The strategy aided the company in identifying new opportunities for the expansion of single-cell multi-omics in the drug development and research fields.
This study forecasts revenue at global, regional, and country levels from 2020 to 2032. Spherical Insights has segmented the global single-cell omics market based on the below-mentioned segments:
Single-Cell Omics Market, Type Analysis
- Single-cell Genomics
- Single-cell Transcriptomics
Single-Cell Omics Market, Application Analysis
Single-Cell Omics Market, End-User Analysis
- Pharma & Biotech Companies
- Hospital Laboratories
- Academic and Research Organizations
Single-Cell Omics Market, Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Need help to buy this report?